A study to improve tracking of opioid use in the fentanyl era
Part of Mental health clinical trials.
This study aims to develop a better tool for recalling and tracking opioid use patterns, especially with fentanyl. It may help people who use opioids outside of medical settings to more accurately report their use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You use opioids (such as heroin or fentanyl) obtained outside of a pharmacy or medical setting at least once a week.
- You can read and understand English.
- You are willing to provide written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with opioid use disorder remember personal events. You'll do tasks on a cellphone and at home while taking medication for opioid use disorder.
This trial tests a way to quickly start buprenorphine (a medication for opioid addiction) in an outpatient clinic for people who use fentanyl. It aims to make starting treatment easier and faster, without needing to go through full withdrawal first.
This Phase 3 study tests whether using smartphones can help people with opioid-use disorder stick with treatment and recover more successfully. It focuses on people starting or already in treatment using methadone or buprenorphine, with support delivered through the study app or messages.
This study tests a new way to start methadone treatment (called 'MethaLoad') for people with opioid use disorder who have used fentanyl. If you qualify, you will receive methadone to help manage withdrawal and reduce cravings, and the doctors will closely monitor your safety and response.
This study is developing a questionnaire to better measure opioid withdrawal symptoms. By participating, you'll help create a tool that may improve how withdrawal is assessed in future care and research.
This Phase 2 study looks at what opioid withdrawal looks like in the body and whether they can measure it in a meaningful way. You may join if you have an opioid use disorder, can show physical dependence, and are interested in tapering (gradually reducing) opioids under study care.
Hear when a new Substance Use Disorders (SUDs) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.